Quarterly Results (Detail) (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended																12 Months Ended
	Jan. 28, 2012		Oct. 29, 2011		Jul. 30, 2011		Apr. 30, 2011		Jan. 29, 2011		Oct. 30, 2010		Jul. 31, 2010		May 01, 2010		Jan. 28, 2012		Jan. 29, 2011		Jan. 30, 2010
Quarterly Financial Information [Line Items]
Sales	$ 1,502		$ 1,394		$ 1,275		$ 1,452		$ 1,392		$ 1,280		$ 1,096		$ 1,281		$ 5,623		$ 5,049		$ 4,854
Gross margin	480	[1]	453	[1]	388	[1]	475	[1]	430	[1]	388	[1]	305	[1]	393	[1]	1,796	[1]	1,516	[1]
Operating profit	122	[2]	106	[2]	59	[2]	150	[2]	90	[2]	74	[2]	11	[2]	87	[2]	437	[2]	262	[2]	80
Net income	$ 81	[3]	$ 66		$ 37		$ 94		$ 57	[3],[4]	$ 52		$ 6		$ 54		$ 278		$ 169		$ 48
Basic earnings per share:	$ 0.53		$ 0.43		$ 0.24		$ 0.61		$ 0.36		$ 0.33		$ 0.04		$ 0.35		$ 1.81		$ 1.08		$ 0.30
Diluted earnings per share:	$ 0.53		$ 0.43		$ 0.24		$ 0.60		$ 0.36		$ 0.33		$ 0.04		$ 0.34		$ 1.80		$ 1.07		$ 0.30

[1] Gross margin represents sales less cost of sales.

[2] Operating profit represents income from continuing operations before income taxes, interest expense, net, and non-operating income.

[3] During the fourth quarters of 2011 and 2010, the Company recorded impairment charges of $5 million and $10 million, respectively, related to its CCS tradename.

[4] During the fourth quarter of 2010, a realized gain of $2 million was recorded related to the Reserve International Fund, a money-market investment.